Search results for "Tumor necrosis factor."

showing 10 items of 848 documents

Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study

2017

AIM To report adalimumab (Ada) efficacy on articular-gastrointestinal disease and health-related quality of life (HRQoL) in patients with enteropathic spondyloarthritis (ES). METHODS A cohort of 52 patients with ES was evaluated in the departments of gastroenterology and internal medicine. At baseline, all patients underwent assessment by an integrated gastro-rheumatologic evaluation of articular and gastrointestinal activity, as well patient reported outcomes (PROs) of the HRQoL questionnaires. After this integrated evaluation and following a specific working flowchart, the Ada anti-tumor necrosis factor (TNF)-inhibitor was assigned to a cohort of 30 patients and its clinical efficacy was …

AdultMalemedicine.medical_specialtyTime FactorsTumor necrosis factor-inhibitorMultidisciplinary studyObservational StudyInflammatory bowel diseasesInflammatory bowel diseaseWorkflowEnteropathic spondyloarthriti03 medical and health sciences0302 clinical medicineCrohn DiseaseClinimetric assessmentInternal medicineSpondylarthritisTumor necrosis factor-inhibitorsAdalimumabHumansMedicinePatient Reported Outcome MeasuresPatient reported outcomes030203 arthritis & rheumatologyBiological ProductsTumor Necrosis Factor-alphabusiness.industryRemission InductionAdalimumabGastroenterologyInflammatory Bowel DiseasesGeneral MedicineMiddle AgedPatient reported outcomeEnteropathic spondyloarthritisClinimetric assessment; Enteropathic spondyloarthritis; Inflammatory bowel diseases; Multidisciplinary evaluation; Patient reported outcomes; Tumor necrosis factor-inhibitors; GastroenterologyTreatment OutcomeMultidisciplinary evaluationAntirheumatic AgentsCritical PathwaysQuality of LifeColitis UlcerativeFemale030211 gastroenterology & hepatologyObservational studybusinessmedicine.drug
researchProduct

Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transpl…

2008

SUMMARY: Aim:  To evaluate whether or not transforming growth factor-beta1 is related to inflammation markers and to intercellular and vascular cell adhesion molecules in patients with stable renal transplantation. Methods:  Serum concentrations of transforming growth factor-beta1, tumour necrosis factor-alpha, C-reactive protein and adhesion molecules were analysed in 33 renal transplanted patients, 33 patients with chronic renal insufficiency (matched to the transplanted group for level of renal function), and 33 hypertensives with normal renal function. anova, Student's t-test and simple regression analysis were used to analyse the data. Results:  Transplanted patients showed higher valu…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentIntercellular Adhesion Molecule-1Renal functionVascular Cell Adhesion Molecule-1Transforming Growth Factor beta1Internal medicinemedicineHumansRenal Insufficiency ChronicKidney transplantationInflammationbiologyCell adhesion moleculebusiness.industryTumor Necrosis Factor-alphaC-reactive proteinGraft SurvivalGeneral MedicineTransforming growth factor betaMiddle Agedmedicine.diseaseIntercellular Adhesion Molecule-1Kidney TransplantationTransplantationEndocrinologyCytokineC-Reactive ProteinCross-Sectional StudiesNephrologyCase-Control StudiesHypertensionbiology.proteinEndothelium VascularbusinessBiomarkersGlomerular Filtration RateNephrology (Carlton, Vic.)
researchProduct

Inflammation and endothelial activation are linked to renal function in long-term kidney transplantation

2006

The aim of this study was to investigate the relationships between inflammation and adhesion molecules in long-term kidney transplantation. We measured serum concentrations of tumor necrosis factor-alpha (TNFalpha) and intercellular and vascular cell adhesion molecules (ICAM-1 and VCAM-1) in 35 renal transplant recipients (mean age of transplantation 5 +/- 3 years) and in 35 chronic renal insufficiency (CRI) patients; twenty-six healthy subjects were enrolled as controls. Transplanted showed higher values than controls of TNFalpha (P < 0.0001), ICAM-1 (P < 0.0001), and VCAM-1 (P < 0.0001). CRI group as well exhibited higher concentrations than controls of TNFalpha (P < 0.0001), ICAM-1 (P < …

AdultMalemedicine.medical_specialtyVascular Cell Adhesion Molecule-1Renal functionInflammationKidney Function TestsEndothelial activationchemistry.chemical_compoundInternal medicineCadavermedicineHumansInflammation endothelial activation kidney transplantationKidney transplantationInflammationTransplantationCreatinineTumor Necrosis Factor-alphabusiness.industryMiddle AgedIntercellular Adhesion Molecule-1medicine.diseaseKidney TransplantationTissue DonorsTransplantationEndocrinologyBlood pressurechemistryTumor necrosis factor alphaEndothelium Vascularmedicine.symptombusinessBiomarkersGlomerular Filtration Rate
researchProduct

Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.

2011

To evaluate adalimumab therapy in refractory uveitis.Prospective case series.A total of 131 patients with refractory uveitis and intolerance or failure to respond to prednisone and at least 1 other systemic immunosuppressive drug participated.Patients received a 40 mg adalimumab subcutaneous injection every other week for 6 months. The associated immunosuppressants were tapered after administering 3 adalimumab injections (week 6).Degree of anterior and posterior chamber inflammation (Standardization of Uveitis Nomenclature Working Group criteria), immunosuppression load (as defined by Nussenblatt et al), visual acuity (logarithm of the minimal angle of resolution [logMAR]), and macular thic…

AdultMalemedicine.medical_specialtyVisual acuityAdolescentInjections SubcutaneousAnti-Inflammatory AgentsDrug ResistanceVisual AcuityArthritisAntibodies Monoclonal HumanizedUveitisRefractoryPrednisoneInternal medicineAdalimumabMedicineHumansMacula LuteaProspective StudiesPars PlanitisProspective cohort studyChildGlucocorticoidsbusiness.industryTumor Necrosis Factor-alphaAdalimumabOff-Label Usemedicine.diseaseSurgeryOphthalmologyMethotrexateTreatment OutcomeChild PreschoolCyclosporineFemalemedicine.symptombusinessUveitisTomography Optical Coherencemedicine.drugOphthalmology
researchProduct

Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximab.

2002

Abstract Background: Psoriatic skin lesions in patients with Crohn's disease or psoriatic arthritis have shown improvement during infliximab treatment. Objective: The purpose of our study was to systematically assess the effects of infliximab in patients with psoriatic skin lesions. Methods: Eight patients with severe psoriasis were enrolled in an open-label clinical trial. Patients received infliximab, 5 mg/kg, intravenously at weeks 0, 2, and 6. The Psoriasis Area and Severity Index (PASI) was used to monitor disease activity at weeks 0, 2, 4, 6, 8, 10, and 14. Week 10 was the end point of the treatment phase; week 14 was the follow-up end point. Pruritus was assessed on a scale of 0 to 3…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentAcanthosisDermatologyGastroenterologySeverity of Illness IndexPsoriatic arthritisPsoriasis Area and Severity IndexInternal medicinePsoriasisBiopsymedicineHumansPsoriasisAdverse effectInfusions IntravenousChemotherapymedicine.diagnostic_testbusiness.industryTumor Necrosis Factor-alphaAntibodies MonoclonalMiddle Agedmedicine.diseaseInfliximabInfliximabSurgeryTreatment OutcomeFemaleDermatologic Agentsbusinessmedicine.drugJournal of the American Academy of Dermatology
researchProduct

Effects of mud-pack treatment on plasma cytokine and soluble adhesion molecule levels in healthy volunteers

2001

Abstract Background : The suggested hypothesis of a direct anti-inflammatory property of mud-pack treatment has led us to speculate that its action on the cytokine network might counteract the heat-stress-related effects on platelet and endothelial cell function often reported following hot-spring baths. Therefore, the present study was designed to investigate the effects of a cycle of 12 daily mud-pack treatments on bio-humoral markers of inflammation, as well as on markers of in vivo platelet and/or endothelial cell activation, in plasma samples obtained from healthy volunteers. Methods : Blood samples were obtained before ( T 0 ), at the end of the first treatment ( T 1 ) and after a cyc…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryHematocritBiochemistrymud-pack treatmentBlood cellLeukocyte CountIn vivoReference ValuesInternal medicinemedicineHumansPlateletadhesion moleculesmedicine.diagnostic_testCell adhesion moleculeChemistryInterleukin-6Platelet CountTumor Necrosis Factor-alphaMud TherapyBiochemistry (medical)General MedicineHyperthermia InducedMiddle AgedPlatelet ActivationcytokinesEndothelial stem cellP-Selectinmedicine.anatomical_structureEndocrinologyCytokineHematocritHemostasisImmunologyadhesion molecules; cytokines; mud-pack treatmentFemaleEndothelium VascularE-SelectinCell Adhesion MoleculesBiomarkersInterleukin-1
researchProduct

Protein supplementation increases postexercise plasma myostatin concentration after 8 weeks of resistance training in young physically active subject…

2015

Abstract Myostatin (MSTN) is a negative regulator of muscle growth even if some studies have shown a counterintuitive positive correlation between MSTN and muscle mass (MM). Our aim was to investigate the influence of 2 months of resistance training (RT) and diets with different protein contents on plasma MSTN, interleukin 1 beta (IL-1β), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), and insulin-like growth factor 1 (IGF-1). Eighteen healthy volunteers were randomly divided in two groups: high protein (HP) and normal protein (NP) groups. Different protein diet contents were 1.8 and 0.85 g of protein·kg bw(-1)·day(-1) for HP and NP, respectively. Subjects underwent 8 weeks of st…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentInterleukin-1betanutritional supplementMedicine (miscellaneous)MyostatinMuscle hypertrophyYoung AdultInternal medicinecytokinemedicineHumansInsulin-Like Growth Factor IMuscle SkeletalInterleukin 6Nutrition and DieteticsexercisebiologyInterleukin-6Tumor Necrosis Factor-alphaGrowth factorResistance trainingResistance TrainingProtein supplementationEndocrinologymyostatinDietary SupplementsBody Compositionbiology.proteinLean body massTumor necrosis factor alphaDietary ProteinsFull Communicationsdiet
researchProduct

Circulating Levels of Adhesion Molecules in Chronic Kidney Disease Correlate with the Stage of Renal Disease and with C-Reactive Protein

2007

Patients with chronic renal failure (CRF) suffer from a series of complications linked to the atherosclerotic process in which the endothelial dysfunction mediated by the activation of some adhesion molecules plays an important role. This study aims to evaluate circulating levels of intercellular adhesion molecules-1 (ICAM-1) and vascular cell adhesion molecules-1 (VCAM-1) in patients with predialysis CRF, on maintenance hemodialysis (HD) and after kidney transplantation (KTx) and to correlate them with some inflammation and nutritional indexes.Thirty two patients with predialysis CRF, 30 on maintenance HD, 36 after KTx and 28 subjects as a control group (C) were included in this study. Cir…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentSerum albuminVascular Cell Adhesion Molecule-1Enzyme-Linked Immunosorbent AssayFibrinogenRenal DialysisInternal medicinemedicineHumansEndothelial dysfunctionAgedAged 80 and overbiologyTumor Necrosis Factor-alphaCell adhesion moleculebusiness.industryC-reactive proteinAlbuminGeneral MedicineMiddle AgedIntercellular Adhesion Molecule-1medicine.diseaseKidney TransplantationC-Reactive ProteinEndocrinologyImmunologybiology.proteinKidney Failure ChronicFemaleKidney DiseasesHemodialysisbusinessKidney diseasemedicine.drugArchives of Medical Research
researchProduct

Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.

2008

Stroke outcome is determined by delayed neuronal cell death and edema formation. TWEAK, a cytokine of the TNF superfamily, and its membrane receptor Fn14 promote ischemia-induced neuronal apoptosis and leakage of the blood-brain barrier. Both TWEAK and Fn14 are upregulated in experimental stroke models. In this study, we investigated whether TWEAK and Fn14 are upregulated in stroke patients. We measured serum concentrations of TWEAK in stroke patients and matched control subjects by ELISA. Expression of Fn14 in the brain was evaluated by real-time RT-PCR and immunohistochemistry. TWEAK serum concentrations were elevated in stroke patients. In autopsy samples, we found elevated mRNA levels o…

AdultMalemedicine.medical_treatmentEnzyme-Linked Immunosorbent AssayFunctional LateralityReceptors Tumor Necrosis FactorCerebral edemaBrain ischemiaCell surface receptorMedicineHumanscardiovascular diseasesRNA MessengerReceptorStrokeCytokine TWEAKAgedAged 80 and overbusiness.industryCerebral infarctionBrainCytokine TWEAKMiddle Agedmedicine.diseaseUp-RegulationStrokeCytokineNeurologyTWEAK ReceptorCase-Control StudiesImmunologyTumor Necrosis FactorsFemaleNeurology (clinical)businessJournal of the neurological sciences
researchProduct

Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations.

2003

Objective To find new aspects of the systemic involvement of the Immune System in psoriasis, we determined serum levels of interleukin-18 (IL-18) (Th1-inducing factor cytokine), CD30 (Th2 marker) and sICAM-1 (adhesion molecule). In addition we evaluated the correlation between these molecules and psoriasis area and severity index (PASI). Background Psoriasis is associated to an overexpression of Th1 cytokines and a relative underexpression of Th2 cytokines. IL-18 plays an important role in inducing Th1 response because it is a potent inductor of synthesis of IFN-γ, TNF and other mediators. The two major sources of IL-18 are monocytes and macrophages but also human keratinocytes constitutive…

AdultMalemedicine.medical_treatmentKi-1 AntigenDermatologySeverity of Illness IndexImmune systemPsoriasis Area and Severity IndexPsoriasisMedicineHumansPsoriasisICAM-1business.industryCase-control studyInterleukin-18medicine.diseaseIntercellular Adhesion Molecule-1Infectious DiseasesCytokineCase-Control StudiesImmunologyInterleukin 18Tumor necrosis factor alphaFemalebusinessJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct